Loading...

Scholar Rock Holding Corporation

SRRK•NASDAQ
Healthcare
Biotechnology
$46.48
$-1.00(-2.11%)
U.S. Market opens in 49h 27m

Scholar Rock Holding Corporation (SRRK) Stock Overview

Explore Scholar Rock Holding Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio-14.18
EPS (TTM)$-3.29
ROE-1.46%
Fundamental Analysis

AI Price Forecasts

1 Month$34.44
3 Months$33.48
1 Year Target$60.19

SRRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scholar Rock Holding Corporation (SRRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $60.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.18 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.11%
5-Day Change
-8.52%
1-Month Change
9.88%
3-Month Change
4.94%
6-Month Change
56.60%
Year-to-Date (YTD) Change
5.52%
1-Year Change
35.19%
3-Year Change
533.24%
5-Year Change
28.97%
All-Time (Max) Change
199.87%

Contact Information

https://scholarrock.com
857 259 3860
301 Binney Street, Cambridge, MA, 02142

Company Facts

128 Employees
IPO DateMay 25, 2018
CountryUS
Actively Trading

Frequently Asked Questions